Miles Jennings is a corporate associate in the Silicon Valley office of Latham & Watkins. Mr. Jennings represents public and private technology, life science, blockchain, and other emerging companies, as well as the entities that finance them. He advises startups through their entire life cycle, from formation through growth stages and exits. His extensive transactional experience includes:
- Venture capital financings
- Initial public offerings (IPOs) and other public securities offerings
- Cryptocurrency structured financings and prefunctional token sales
- Mergers and acquisitions
- General company representation
Mr. Jennings acts as an outside advisor to ConsenSys' Tachyon Accelerator Program and Anduin Transactions.
Mr. Jennings received his JD, magna cum laude, from the Pepperdine University School of Law, where he was a fellow in the Palmer Center for Entrepreneurship & the Law. He received his BS in Mechanical Engineering from the University of California, Los Angeles.
Mr. Jennings’ technology and cryptocurrency representative work includes:
- ConsenSys, ConsenSys Ventures, Tachyon Accelerator
- Token Foundry
- Meritech Capital
- Formation 8 and 8VC
- Bill and Melinda Gates Foundation
- Andreessen Horowitz
- Bitwise
- Halo Neuro
- Clarify Health Solutions
- Zeus Living
- Nanosys
- OpenGov
- PresenceLearning
- Pipedrive
- Proterra
- Kymeta
- Steel House
Mr. Jennings’ life sciences representative work includes:
- Satsuma Pharmaceuticals (public)
- CytomX Therapeutics (public)
- Unity Biotechnology (public)
- Aimmune Therapeutics (public)
- Corvus Pharmaceuticals (public)
- Menlo Therapeutics (public)
- Myokardia (public)
- Hexagon Bio
- Omniome
- Mercator Medsystems
- Indalo Therapeutics
- Abingworth